• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 型糖尿病患者一级亲属的 10 年随访:回顾性队列中自身免疫生物标志物的存在与糖尿病的进展。

Ten years follow up of first degree relatives of type 1 diabetes patients: presence of autoimmune biomarkers and the progression to diabetes in a retrospective cohort.

机构信息

Departamento de Nutrologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil,

Departamento de Nutrologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil.

出版信息

Arch Endocrinol Metab. 2021 Nov 3;65(4):436-442. doi: 10.20945/2359-3997000000370. Epub 2021 Jul 16.

DOI:10.20945/2359-3997000000370
PMID:34283897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10522178/
Abstract

OBJECTIVE

The aim of the study was to assess the autoimmunity in first degrees relatives (FDR) of patients with type 1 diabetes (T1DM) and the progression to T1DM after 10 years of follow up in the Brazilian population.

METHODS

Non-diabetic FDR of T1DM patients were interviewed and blood was drawn for autoantibodies measurement (GADA, IA-2A, IAA, ZnT8A). Serum samples were analyzed by standard radioligand binding assays performed at the Federal University of Rio de Janeiro (GADA, IAA and IA2A), and at the Skäne University Hospital, Sweden (ZnT8A). The FDR were interviewed by phone after 10 years to determine if they had developed T1DM. Descriptive statistical analysis was performed and results were described as means and standard deviation (SD).

RESULTS

81 individuals were analyzed. Thirteen subjects had positive autoantibodies associated with T1DM.10 were positive for 1 autoantibody and 3 subjects were positive for multiple autoantibodies (1 of them showed positivity for 2 autoantibodies - GADA, ZnT8A - and the other two were positive for 3 autoantibodies - GADA, IA2A, ZnT8A). The 3 subjects with multiple positive autoantibodies developed T1DM within 10 years.

CONCLUSION

In Brazilian FDR of T1DM patients, the positivity for multiple autoantibodies indicate a greater chance of progression to T1DM, similar to observed in Caucasians. ZnT8A was helpful in the risk assessment for T1DM development.

摘要

目的

本研究旨在评估 1 型糖尿病(T1DM)患者一级亲属(FDR)的自身免疫情况,并在巴西人群中进行 10 年随访后评估其发展为 T1DM 的情况。

方法

对 T1DM 患者的非糖尿病 FDR 进行访谈,并抽取血液进行自身抗体检测(GADA、IA-2A、IAA、ZnT8A)。血清样本由里约热内卢联邦大学(GADA、IAA 和 IA2A)和瑞典 Skäne 大学医院(ZnT8A)进行标准放射配体结合分析。在 10 年后,通过电话对 FDR 进行访谈,以确定他们是否患有 T1DM。进行描述性统计分析,结果以均值和标准差(SD)表示。

结果

共分析了 81 名个体。13 名受试者存在与 T1DM 相关的阳性自身抗体。其中 10 名受试者存在 1 种自身抗体阳性,3 名受试者存在多种自身抗体阳性(其中 1 名存在 2 种自身抗体阳性-GADA、ZnT8A-,另外 2 名存在 3 种自身抗体阳性-GADA、IA2A、ZnT8A)。这 3 名存在多种阳性自身抗体的受试者在 10 年内发展为 T1DM。

结论

在巴西 T1DM 患者的 FDR 中,多种自身抗体的阳性提示发展为 T1DM 的可能性更大,这与白种人观察到的结果相似。ZnT8A 有助于评估 T1DM 发病风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b6/10522178/7fe8cfd36bb6/2359-4292-aem-65-04-0436-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b6/10522178/7fe8cfd36bb6/2359-4292-aem-65-04-0436-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b6/10522178/7fe8cfd36bb6/2359-4292-aem-65-04-0436-gf01.jpg

相似文献

1
Ten years follow up of first degree relatives of type 1 diabetes patients: presence of autoimmune biomarkers and the progression to diabetes in a retrospective cohort.1 型糖尿病患者一级亲属的 10 年随访:回顾性队列中自身免疫生物标志物的存在与糖尿病的进展。
Arch Endocrinol Metab. 2021 Nov 3;65(4):436-442. doi: 10.20945/2359-3997000000370. Epub 2021 Jul 16.
2
Prevalence of islet autoantibodies in Thai juvenile-onset type 1 diabetes.泰国青少年1型糖尿病患者中胰岛自身抗体的患病率
Pediatr Int. 2018 Nov;60(11):1002-1007. doi: 10.1111/ped.13687.
3
The expression of GADA, ZnT8A and IA-2A in patients with type 1 diabetes mellitus with thyroid disease and their correlation with thyroid autoantibodies.1 型糖尿病合并甲状腺疾病患者中 GADA、ZnT8A 和 IA-2A 的表达及其与甲状腺自身抗体的相关性。
Eur Rev Med Pharmacol Sci. 2023 Dec;27(24):12051-12057. doi: 10.26355/eurrev_202312_34803.
4
Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.胰岛素瘤抗原 2 和锌转运体 8 自身抗体的筛查:一种具有成本效益且与年龄无关的策略,可在 1 型糖尿病患者的亲属中识别出快速进展至临床发病的个体。
Clin Exp Immunol. 2013 Jan;171(1):82-90. doi: 10.1111/j.1365-2249.2012.04675.x.
5
Evaluation of the RSR 3 screen ICA™ and 2 screen ICA™ as screening assays for type 1 diabetes in Sweden.评价 RSR 3 屏幕 ICA™ 和 2 屏幕 ICA™ 作为瑞典 1 型糖尿病的筛查检测方法。
Acta Diabetol. 2022 Jun;59(6):773-781. doi: 10.1007/s00592-022-01856-5. Epub 2022 Feb 26.
6
Autoimmune thyroid disease correlates to islet autoimmunity on zinc transporter 8 autoantibody.自身免疫性甲状腺疾病与锌转运体8自身抗体相关的胰岛自身免疫有关。
Endocr Connect. 2021 May 19;10(5):534-542. doi: 10.1530/EC-20-0650.
7
Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5.谷氨酸脱羧酶自身抗体在成人隐匿性自身免疫性糖尿病(LADA)中占主导地位,但不足以识别大多数中国成年非胰岛素依赖型自身免疫性糖尿病患者:LADA中国研究5。
Acta Diabetol. 2015 Dec;52(6):1121-7. doi: 10.1007/s00592-015-0799-8. Epub 2015 Aug 5.
8
Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus.锌转运体 8 自身抗体(ZnT8A)有助于区分成人隐匿性自身免疫性糖尿病(LADA)与表型 2 型糖尿病。
Diabetes Metab Res Rev. 2013 Jul;29(5):363-8. doi: 10.1002/dmrr.2396.
9
Screening Strategy for Islet Autoantibodies in Diabetes Patients of Different Ages.不同年龄段糖尿病患者胰岛自身抗体的筛查策略。
Diabetes Technol Ther. 2022 Mar;24(3):212-219. doi: 10.1089/dia.2021.0177.
10
Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials.胰岛素瘤相关蛋白 2β(IA-2β)和锌转运蛋白-8 抗体筛查对选择 1 型糖尿病患者快速进展至临床发病的一级亲属的预测能力:对预防试验的影响。
Diabetologia. 2010 Mar;53(3):517-24. doi: 10.1007/s00125-009-1618-y. Epub 2009 Nov 29.

引用本文的文献

1
Risk for progression to type 1 diabetes in first-degree relatives under 50 years of age.50 岁以下一级亲属发生 1 型糖尿病的风险。
Front Endocrinol (Lausanne). 2024 Aug 12;15:1411686. doi: 10.3389/fendo.2024.1411686. eCollection 2024.

本文引用的文献

1
2. Classification and Diagnosis of Diabetes: .2. 糖尿病的分类和诊断: 。
Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31. doi: 10.2337/dc20-S002.
2
A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk.1 型糖尿病遗传风险评分可预测高危个体胰岛自身免疫的进展和 1 型糖尿病的发生。
Diabetes Care. 2018 Sep;41(9):1887-1894. doi: 10.2337/dc18-0087. Epub 2018 Jul 12.
3
Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives.
年龄和抗体类型对1型糖尿病亲属中从单一自身抗体发展为多种自身抗体的影响。
J Clin Endocrinol Metab. 2017 Aug 1;102(8):2881-2886. doi: 10.1210/jc.2017-00569.
4
Importance of Zinc Transporter 8 Autoantibody in the Diagnosis of Type 1 Diabetes in Latin Americans.锌转运体 8 自身抗体在拉丁美洲 1 型糖尿病诊断中的重要性。
Sci Rep. 2017 Mar 16;7(1):207. doi: 10.1038/s41598-017-00307-4.
5
Predictors of slow progression to diabetes in children with multiple islet autoantibodies.具有多种胰岛自身抗体的儿童糖尿病缓慢进展的预测因素。
J Autoimmun. 2016 Aug;72:113-7. doi: 10.1016/j.jaut.2016.05.010. Epub 2016 May 30.
6
Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.1型糖尿病症状前分期:美国青少年糖尿病研究基金会、美国内分泌学会及美国糖尿病协会的科学声明
Diabetes Care. 2015 Oct;38(10):1964-74. doi: 10.2337/dc15-1419.
7
Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY).从胰岛自身抗体出现到儿童早期糖尿病进展的预测因素:青少年糖尿病环境决定因素研究(TEDDY)
Diabetes Care. 2015 May;38(5):808-13. doi: 10.2337/dc14-2426. Epub 2015 Feb 9.
8
The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study.遗传易患儿童中糖尿病相关自身抗体的6年发病率:TEDDY研究
Diabetologia. 2015 May;58(5):980-7. doi: 10.1007/s00125-015-3514-y. Epub 2015 Feb 10.
9
Progression from single to multiple islet autoantibodies often occurs soon after seroconversion: implications for early screening.从单一胰岛自身抗体进展为多种胰岛自身抗体的情况通常在血清转化后不久就会出现:对早期筛查的启示。
Diabetologia. 2015 Feb;58(2):411-3. doi: 10.1007/s00125-014-3443-1. Epub 2014 Nov 20.
10
Zinc transporter-8 autoantibodies can replace IA-2 autoantibodies as a serological marker for juvenile onset type 1 diabetes in India.在印度,锌转运体8自身抗体可替代胰岛抗原2自身抗体作为青少年起病的1型糖尿病的血清学标志物。
Indian J Endocrinol Metab. 2014 May;18(3):345-9. doi: 10.4103/2230-8210.131174.